Skip to content
Board of directors
Collaborations and partnerships
Research & development
Immunotherapy of cancer
Board of Directors and Management
Articles of association
Share and shareholders
Preferential Rights Issue Q4 2021
Preferential rights issue Q1 2021
Full Year Report 2016
17 Feb 2017
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings".
Choose what kind of cookies to accept. Your choice will be saved for one year.
These cookies are not optional. They are needed for the website to function.
In order for us to improve the website's functionality and structure, based on how the website is used.
In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.